Gene therapy with plasmid IL-12 delivered by electroporation in patients with malignant melanoma: Results of first human Phase I trial

被引：2
|
作者：
Heller, R.
DeConti, R.
Messina, J.
Andrews, S.
Urbas, P.
Ugen, K.
Puleo, C.
Sondak, V.
Riker, A.
Daud, A.
机构：
[1] Univ S Florida, Tampa, FL USA
[2] Univ S Florida, Ctr Mol Delivey, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Univ S Florida, Dept Interdisciplinary Oncol, Tampa, FL USA
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70345-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
340
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [21] The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent
    Lisec, Barbara
    Markelc, Bostjan
    Valentinuzzi, Katja Ursic
    Sersa, Gregor
    Cemazar, Maja
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [22] Production of IL-12 from gene modified human dermal fibroblasts: A preclinical study for IL-12 cancer gene therapy
    Chaehwa Park
    Won-Ki Kang
    Misook Oh
    Won Seog Kim
    Jung-Hyun Yang
    Michael T Lotze
    Sunyoung Kim
    Keunchil Park
    Chan H Park
    Experimental & Molecular Medicine, 1997, 29 : 65 - 69
  • [23] Production of IL-12 from gene modified human dermal fibroblasts: A preclinical study for IL-12 cancer gene therapy
    Park, C
    Kang, WK
    Oh, M
    Kim, WS
    Yang, JH
    Lotze, MT
    Kim, S
    Park, K
    Park, CH
    EXPERIMENTAL AND MOLECULAR MEDICINE, 1997, 29 (01): : 65 - 69
  • [24] Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma
    Tarhini, Ahmad A.
    Eroglu, Zeynep
    Eljilany, Islam
    Zager, Jonathan S.
    Gonzalez, Ricardo J.
    Sarnaik, Amod A.
    Cruse, Carl Wayne
    Khushalani, Nikhil I.
    De Aquino, Deanryan B.
    Abraham, Edith
    Acevedo, Diana M.
    Richards, Allison
    Schell, Michael J.
    Kalos, Denise
    Chen, Pei-Ling
    Messina, Jane L.
    Canton, David A.
    Sondak, Vernon K.
    CLINICAL CANCER RESEARCH, 2024, 30 (23) : 5333 - 5341
  • [25] Robust Immunogenicity after HIV DNA Vaccination with IL-12 Plasmid Cytokine Adjuvant Delivered via Electroporation in HIV Uninfected Adults
    Kalams, S. A.
    Edupuganti, S.
    Elizaga, M.
    Metch, B.
    Eldridge, J.
    Sherwat, A.
    De Rosa, S.
    Khan, A. S.
    Sardesai, N.
    Weiner, D. B.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A131 - A131
  • [26] Boron neutron capture therapy for cutaneous angiosarcoma and malignant melanoma: First in-human phase I clinical trial
    Kashihara, Tairo
    Nakamura, Satoshi
    Yamazaki, Naoya
    Takahashi, Akira
    Namikawa, Kenjiro
    Ogata, Dai
    Nakano, Eiji
    Okuma, Kae
    Kaneda, Tomoya
    Mori, Taisuke
    Ito, Kimiteru
    Itami, Jun
    Shimada, Kazuaki
    Nakagama, Hitoshi
    Igaki, Hiroshi
    RADIOTHERAPY AND ONCOLOGY, 2025, 202
  • [27] IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma
    Lucas, ML
    Heller, L
    Coppola, D
    Heller, R
    MOLECULAR THERAPY, 2002, 5 (06) : 668 - 675
  • [28] Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses
    Greaney, Samantha K.
    Algazi, Alain P.
    Tsai, Katy K.
    Takamura, Kathryn T.
    Chen, Lawrence
    Twitty, Christopher G.
    Zhang, Li
    Paciorek, Alan
    Pierce, Robert H.
    Le, Mai H.
    Daud, Adil, I
    Fong, Lawrence
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (02) : 246 - 254
  • [29] PD-1 peptide/IL-12 combination gene therapy for the treatment of melanoma
    Heller, Loree
    Shi, Guilan
    Synowiec, Jody
    Heller, Richard
    CANCER RESEARCH, 2022, 82 (12)
  • [30] IL-12 and PD-1 peptide combination gene therapy for the treatment of melanoma
    Heller, Loree C.
    Shi, Guilan
    Conniff, Amanda Sales
    Singh, Julie
    Mannarino, Samantha
    Synowiec, Jody
    Heller, Richard
    MOLECULAR THERAPY NUCLEIC ACIDS, 2024, 35 (03):
12345